» Articles » PMID: 31449742

Pharmacometrics in Australasia-Twenty Years of Population Approach Group of Australia and New Zealand

Overview
Publisher Wiley
Specialty Pharmacology
Date 2019 Aug 27
PMID 31449742
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region.

Alasmari M, Albusaysi S, Elhefnawy M, Ali A, Altigani K, Almoslem M Saudi Pharm J. 2024; 32(12):102207.

PMID: 39697476 PMC: 11653594. DOI: 10.1016/j.jsps.2024.102207.


Barriers to global pharmacometrics: educational challenges and opportunities across the globe.

Michelet R, Aulin L, Borghardt J, Dalla Costa T, Denti P, Ibarra M CPT Pharmacometrics Syst Pharmacol. 2023; 12(6):743-747.

PMID: 36960632 PMC: 10272295. DOI: 10.1002/psp4.12940.


What "Impact" Do NLME Publications Have Outside Our Community?.

Hennig S, Fischer J, Kloft C CPT Pharmacometrics Syst Pharmacol. 2020; 9(4):191-194.

PMID: 32196956 PMC: 7179956. DOI: 10.1002/psp4.12501.

References
1.
OReilly R, AGGELER P . Studies on coumarin anticoagulant drugs. Initiation of warfarin therapy without a loading dose. Circulation. 1968; 38(1):169-77. DOI: 10.1161/01.cir.38.1.169. View

2.
OReilly R, AGGELER P, Leong L . STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN. J Clin Invest. 1963; 42:1542-51. PMC: 289433. DOI: 10.1172/JCI104839. View